| Temitope Omotayo, PHARMD | |
|
901 Nevin Ave, Skyview Pharmacy, Richmond, CA 94801-3143 | |
| (510) 520-3985 | |
| Not Available |
| Full Name | Temitope Omotayo |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 901 Nevin Ave, Richmond, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013449826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 62404 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Temitope Omotayo, PHARMD 901 Nevin Ave, Skyview Pharmacy, Richmond, CA 94801-3143 Ph: (510) 520-3985 | Temitope Omotayo, PHARMD 901 Nevin Ave, Skyview Pharmacy, Richmond, CA 94801-3143 Ph: (510) 520-3985 |
News Archive
"[W]e are losing the global fight against bad medicines," and though "[s]ome progress is being made," the "problem is that ... crackdowns tend to focus on counterfeit drugs" while a "much bigger public health problem ... is substandard drugs that are the result of shoddy manufacturing and handling - or perhaps worse, deliberate corner-cutting," Roger Bate, a resident scholar at the American Enterprise Institute, writes in an opinion piece in The Hill's "Congress Blog."
Prime Healthcare Services has acquired the 151-bed Encino Campus of Encino-Tarzana Regional Medical Center from Tenet Healthcare Corporation ("Tenet") effective June 1 and will operate the hospital as Encino Hospital Medical Center.
A recently published clinical study in the Journal of the American Medical Association has answered an urgent question that long puzzled ER pediatricians: Is the drug lorazepam really safer and more effective than diazepam - the U.S. Food and Drug Administration-approved medication as first line therapy most often used by emergency room doctors to control major epileptic seizures in children?
Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.
› Verified 4 days ago
Iok I Tang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Macdonald Ave, Richmond, CA 94801 Phone: 510-236-5748 | |
Nicholas Do, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Nevin Ave, Richmond, CA 94801 Phone: 510-307-1515 | |
Jiangyan Du, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Nevin Ave, Richmond, CA 94801 Phone: 510-307-4851 | |
Mr. Paul Pastina, PHARM D CGP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 Pinnacle Ct, 115, Richmond, CA 94801 Phone: 510-235-4246 | |
Mrs. Susan N Kalaei, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4500 Macdonald Ave, T1507, Richmond, CA 94805 Phone: 510-253-1001 Fax: 510-253-1011 | |
Pauline Lai-toledo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Nevin Ave, Richmond, CA 94801 Phone: 510-307-3161 |